Bavarian Nordic Gets Chikungunya Vaccine Boost
Playing Catch-Up With Valneva
Bavarian Nordic is planning regulatory submissions on both sides of the Atlantic next year for its vaccine against chikungunya virus, CHIKV VLP, after it demonstrated protection from the mosquito-borne disease in a second Phase III study.
